- Filed
- Feb 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Dec 31, 2024 | 45.21M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2024 | 46.01M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 49.08M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 49.66M sh |
| Shares Outstanding | Q3 2025 · Dec 31, 2024 | 46.23M sh |
| Capex | Q3 2025 · Dec 31, 2024 | $35.5M |
| Capex | Q3 2025 · Dec 31, 2023 | $43.84M |
| Operating Cash Flow | Q3 2025 · Dec 31, 2024 | $153.77M |
| Operating Cash Flow | Q3 2025 · Dec 31, 2023 | $139.62M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $143.15M |
| Long Term Debt | Q3 2025 · Mar 31, 2024 | $102.53M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $0 |
| Short Term Debt | Q3 2025 · Mar 31, 2024 | $40M |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $129.52M |
| Short Term Investments | Q3 2025 · Mar 31, 2024 | $156.53M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $101.63M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $87.43M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $763.11M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $737.33M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $787.31M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $841.28M |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | $833.18M |
| Stockholders Equity | Q3 2025 · Mar 31, 2023 | $812.06M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $285.75M |
| Current Liabilities | Q3 2025 · Mar 31, 2024 | $312.03M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $646.66M |
| Total Liabilities | Q3 2025 · Mar 31, 2024 | $646.77M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $518.35M |
| Current Assets | Q3 2025 · Mar 31, 2024 | $529.68M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $1.41B |
| Total Assets | Q3 2025 · Mar 31, 2024 | $1.43B |
| Eps Diluted | Q3 2025 · Dec 31, 2024 | $1.07 |
| Eps Diluted | Q3 2025 · Dec 31, 2024 | $2.59 |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | $0.85 |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | $2.68 |
| Eps Basic | Q3 2025 · Dec 31, 2024 | $1.12 |
| Eps Basic | Q3 2025 · Dec 31, 2024 | $2.71 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | $0.88 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | $2.80 |
| Net Income | Q3 2025 · Dec 31, 2024 | $48.57M |
| Net Income | Q3 2025 · Dec 31, 2024 | $119.28M |
| Net Income | Q3 2025 · Dec 31, 2023 | $41.54M |
| Net Income | Q3 2025 · Dec 31, 2023 | $132.94M |
| Operating Income | Q3 2025 · Dec 31, 2024 | $45.24M |
| Operating Income | Q3 2025 · Dec 31, 2024 | $125.13M |
| Operating Income | Q3 2025 · Dec 31, 2023 | $39.39M |
| Operating Income | Q3 2025 · Dec 31, 2023 | $123.97M |
| Gross Profit | Q3 2025 · Dec 31, 2024 | $116.56M |
| Gross Profit | Q3 2025 · Dec 31, 2024 | $345.56M |
| Gross Profit | Q3 2025 · Dec 31, 2023 | $114.35M |
| Gross Profit | Q3 2025 · Dec 31, 2023 | $347.51M |
| Cost Of Revenue | Q3 2025 · Dec 31, 2024 | $216.41M |
| Cost Of Revenue | Q3 2025 · Dec 31, 2024 | $633.13M |
| Cost Of Revenue | Q3 2025 · Dec 31, 2023 | $211.86M |
| Cost Of Revenue | Q3 2025 · Dec 31, 2023 | $639.09M |
| Revenue | Q3 2025 · Dec 31, 2024 | $332.96M |
| Revenue | Q3 2025 · Dec 31, 2024 | $978.69M |
| Revenue | Q3 2025 · Dec 31, 2023 | $326.2M |
| Revenue | Q3 2025 · Dec 31, 2023 | $986.59M |